| abstract |
CGRP-antagonists are disclosed having the general formula (I), in which A, X and R1-R3 have the definition given in claim 1, as well as their tautomers, diastereomers, enantiomers, hydrates, mixtures and salts, as well as their salt hydrates, in particular their physiologically compatible salts with inorganic or organic acids, medicaments containing these compounds, their use and their preparation processes. |